Zack Lynch
Co-founder, General Partner @ Jazz Venture Partners
San Francisco, United States
Zack Lynch is a Series B investor at Jazz Venture Partners in San Francisco focused on Recruiting and Software. Zack Lynch: Zack has a passion for using the brain science of motivation to help people achieve amazing goals. In 2011, he published the best selling book, The Neuro Revolution: How Brain Science Is Changing Our World in the U.S., Japan, Korea, Brazil and China.He is the founder and Chairman of the Neurotechnology Industry Organization, a majortrade association representing over 100 neurotech companies, brain research institutes and patient advocacy groups. He also founded NeuroInsights, a neuroscience-focused market research firm, where he created the NASDAQ NeuroInsights Neurotech Index (NERV), a stock tracking index of public neurotech companies. He sits on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies and the Penn Center for Neuroscience and Society.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Zack Lynch invests in
Stages Zack Lynch invests in
Countries Zack Lynch invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Recruiting 2 (33%)
- Software 1 (17%)
- Wellness 1 (17%)
- Health Care 1 (17%)
- Mobile Apps 1 (17%)
Stage
- Series B 3 (50%)
- Series A 2 (33%)
- Seed 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
JobGet
|
JobGet is the social platform for jobs. It is the fastest job platform for anyone looking for a job in the retail and hospitality industry, reducing the timeline from weeks to minutes. Consistently a Top 10 rated app in the iOs and Android play store helping thousands of job seekers engage with leading employers.Getting a job shouldn’t take hoursfilling online applications and waiting for weeks to hear back. We help accelerate the process with smart matching and a talk, text and video enabled platform.We are currently working with thousands of employers around the US on finding the right staff quickly, as well as helping thousands of jobseekers find their dream jobs within minutes.JobGet is a 2019 MassChallenge winner, as well as a 2019 MIT Inclusive Innovation Challenge Winner. We are looking to reshape the employment landscape for hourly employers and professionals to be instant, accessible, and efficient. | $40M / Series B / Jun 23, 2022 | |
Swing Therapeutics
|
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regaincontrol of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives. | $10.3M / Series A / Jun 16, 2022 | |
AppliedVR
|
AppliedVR offers virtual reality-based treatments that address the complexity of chronic pain. The company's mission is to empower patients with the tools to live life, beyond chronic pain. Rooted in cognitive behavioral therapy and mindfulness, AppliedVR’s EaseVRx is the first VR-based prescription therapeutic to receive Breakthrough DeviceDesignation by the FDA. Offering a comprehensive approach that encompasses the biological, psychological and social factors that influence how people experience chronic pain, EaseVRx enables patients to change the way they process pain and develop new, positive habits and coping skills that improve quality of life.Patients can easily self-administer EaseVRx in the comfort of their own homes, at any time, without restrictions tied to a healthcare professional’s schedule — advancing remote care as well as quality, equity and efficiency in chronic pain management. | $36M / Series B / Nov 11, 2021 | |
|
Swing Therapeutics
|
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regaincontrol of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives. | $9M / Seed / Aug 11, 2021 | |
Pymetrics
|
Pymetrics develops neuroscience-based assessment and prediction technology for staffing services. | $40M / Series B / Sep 27, 2018 | |
|
Pymetrics
|
Pymetrics develops neuroscience-based assessment and prediction technology for staffing services. | $8M / Series A / Sep 20, 2017 |
Co-Investors
About Jazz Venture Partners
JAZZ Venture Partners is the leading venture capital firm focused on technologies that extend the boundaries of human performance. They invest in companies at the intersection of digital technology and neuroscience. They are interested in companies that leverage cutting-edge brain science to inform powerful technology platforms that are impactingthe human experience, such as virtual and augmented reality, immersive video gaming, artificial intelligence, and closed-loop human-computer systems. Their portfolio companies are unlocking human potential in important markets: health, mind-body wellness, peak mental and physical performance, accelerated learning and training, sports, and entertainment.The partners are proven investors, entrepreneurs, neuroscientists, and technologists. They have deep domain experience and unparalleled access to innovative companies, talent, and strategic resources. Their multidisciplinary backgrounds allow us to meaningfully support exceptional entrepreneurs and executives in building category-defining companies.
Jazz Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John F. Harris
Co-Founder and Managing Partner
|
|||
John F. Harris
Co-Founder and Managing Partner
|
|||
John Spinale
Co-Founder, Managing Partner
|
|||
|
Zack Lynch
Co-founder, General Partner
|
|||
Adam Gazzaley
Co-Founder & Chief Scientist
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Zack Lynch invest in?
Zack Lynch invests primarily in Recruiting, Software and Wellness startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Zack Lynch?
Public channels for Zack Lynch include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Zack Lynch last invest?
The most recent investment recorded for Zack Lynch closed in Jun 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
